Schedule 13D ownership disclosure

TRANSLATE BIO INC

Security class unavailable · CUSIP: 89374L104

Event date: 2019-05-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
646,541
Percent of class
1.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-20-001837
Form type
SC 13D/A
Filer
GSK plc
CIK
CIK 1131399
Filed
Feb 14, 2020
Reporting period
May 29, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub